Aromatase inhibitors and breast cancer.

Miller, W R

Miller, W R.

Affiliation

Miller WR; Breast Unit, University of Edinburgh, Western General Hospital, Edinburgh, UK. wmiller@staffmail.ed.ac.uk

Minerva Endocrinol ; 31(1): 27-46, 2006 Mar.

Article in En | MEDLINE | ID: mdl-16498362

Subject(s)

Antineoplastic Agents/therapeutic use; Aromatase Inhibitors/therapeutic use; Breast Neoplasms/drug therapy; Estrogens; Neoplasms, Hormone-Dependent/drug therapy; Adipose Tissue/enzymology; Antineoplastic Agents/pharmacology; Antineoplastic Agents, Hormonal/pharmacology; Antineoplastic Agents, Hormonal/therapeutic use; Aromatase/physiology; Aromatase Inhibitors/pharmacology; Breast/drug effects; Breast/enzymology; Chemotherapy, Adjuvant; Combined Modality Therapy; Drug Resistance, Neoplasm; Estrogen Receptor Modulators/pharmacology; Estrogen Receptor Modulators/therapeutic use; Estrogens/biosynthesis; Female; Humans; Neoadjuvant Therapy; Neoplasm Proteins/antagonists & inhibitors; Neoplasm Proteins/physiology; Randomized Controlled Trials as Topic

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Aromatase Inhibitors / Estrogens / Neoplasms, Hormone-Dependent / Antineoplastic Agents Type of study: Clinical_trials Limits: Female / Humans Language: En Journal: Minerva Endocrinol Year: 2006 Document type: Article

Search on Google

XML

PubMed Links